Orum Therapeutics, a Korean biotechnology developer targeting cancer and rare diseases, has secured a $30 million Series B round from a group including IMM Investment and InterVest.
Smilegate Investment, KTB Network, and Stassets Investment also joined the round, alongside KB Investment and Solidus Investment. The latter two also joined InterVest and LB Investment in an approximately...
Kotak Mahindra Group hopes his longstanding experience in financial services will serve as a differentiator as it looks for deals in India's increasingly popular distressed space
Conservative sovereign wealth investors are increasingly comfortable making direct commitments to venture-oriented technology companies. The strategy appears to suit them but remains to be validated
01VC has secured institutional LP support for its second fund, which closed at $100 million. The early-stage investor plans to deploy it across industrial and enterprise deals in China and Southeast Asia